Ronny Martin

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 13

Top Topics

Candida Albicans

Top Venues

Antimicrobial agents and chemotherapy

Nature communications

Microbiology spectrum

This page only lists publications with an associated author ORCID identifier.

Publications

Hesham Elsaman, Evgeny Golubtsov, Sean Brazil, Natanya Ng, Isabel Klugherz, Ronny Martin, Karl Dichtl, Christoph Müller, Johannes Wagener
Toxic eburicol accumulation drives the antifungal activity of azoles against Aspergillus fumigatus. Nature communications 15 (1) (2024)
Alexander Maximilian Aldejohann, Carolina Menner, Nadja Thielemann, Ronny Martin, Grit Walther, Oliver Kurzai
In vitro activity of ibrexafungerp against clinically relevant echinocandin-resistant Candida strains. Antimicrobial agents and chemotherapy 68 (2) (2024)
Alexander Maximilian Aldejohann, Carolina Menner, Nadja Thielemann, Ronny Martin, Grit Walther, Oliver Kurzai
In vitro activity of ibrexafungerp against clinically relevant echinocandin-resistant Candida strains. Antimicrobial agents and chemotherapy 68 (2) (2024)
Hesham Elsaman, Evgeny Golubtsov, Sean Brazil, Natanya Ng, Isabel Klugherz, Ronny Martin, Karl Dichtl, Christoph Müller, Johannes Wagener
Toxic eburicol accumulation drives the antifungal activity of azoles against Aspergillus fumigatus. Nature communications 15 (1) (2024)
Hanna Stieber, Lara Junghanns, Hannah Wilhelm, Maria Batliner, Alexander Maximilian Aldejohann, Oliver Kurzai, Ronny Martin
The sphingolipid inhibitor myriocin increases Candida auris susceptibility to amphotericin B. Mycoses 67 (4) (2024)
Alexander Maximilian Aldejohann, Carolina Menner, Nadja Thielemann, Ronny Martin, Grit Walther, Oliver Kurzai
In vitro activity of ibrexafungerp against clinically relevant echinocandin-resistant Candida strains. Antimicrobial agents and chemotherapy 68 (2) (2024)
Alexander Maximilian Aldejohann, Carolina Menner, Nadja Thielemann, Ronny Martin, Grit Walther, Oliver Kurzai
In vitro activity of ibrexafungerp against clinically relevant echinocandin-resistant Candida strains. Antimicrobial agents and chemotherapy 68 (2) (2024)
Alexander Maximilian Aldejohann, Carolina Menner, Nadja Thielemann, Ronny Martin, Grit Walther, Oliver Kurzai
In vitro activity of ibrexafungerp against clinically relevant echinocandin-resistant Candida strains. Antimicrobial agents and chemotherapy 68 (2) (2024)
Alexander Maximilian Aldejohann, Carolina Menner, Nadja Thielemann, Ronny Martin, Grit Walther, Oliver Kurzai
In vitro activity of ibrexafungerp against clinically relevant echinocandin-resistant Candida strains. Antimicrobial agents and chemotherapy 68 (2) (2024)
Hesham Elsaman, Evgeny Golubtsov, Sean Brazil, Natanya Ng, Isabel Klugherz, Ronny Martin, Karl Dichtl, Christoph Müller, Johannes Wagener
Toxic eburicol accumulation drives the antifungal activity of azoles against Aspergillus fumigatus. Nature communications 15 (1) (2024)
Alexander Maximilian Aldejohann, Carolina Menner, Nadja Thielemann, Ronny Martin, Grit Walther, Oliver Kurzai
In vitro activity of ibrexafungerp against clinically relevant echinocandin-resistant Candida strains. Antimicrobial agents and chemotherapy (2024)
Enrico Garbe, Nadja Thielemann, Sina Hohner, Animesh Kumar, Slavena Vylkova, Oliver Kurzai, Ronny Martin
Functional analysis of the Candida albicans ECE1 Promoter. Microbiology spectrum (2023)
Christine Dunker, Melanie Polke, Bianca Schulze-Richter, Katja Schubert, Sven Rudolphi, A Elisabeth Gressler, Tony Pawlik, Juan P Prada Salcedo, Maria Joanna Niemiec, Silvia Slesiona-Künzel, Marc Swidergall, Ronny Martin, Thomas Dandekar, Ilse Denise Jacobsen
Rapid proliferation due to better metabolic adaptation results in full virulence of a filament-deficient Candida albicans strain. Nature communications 12 (1) (2021)